Newsroom

Portrait of Susanne Häußler in front of a white background

News

The European Academy of Microbiology (EAM) has announced the election of 95 new Fellows to the network. Among the newly elected members is Prof. Susanne Häußler, head of the department “Molecular Bacteriology” at the Helmholtz Centre for Infection Research (HZI) and at the TWINCORE – Centre for Experimental and Clinical Infection Research, a joint institution of the HZI and Hannover Medical School. Häußler studies multidrug-resistant pathogens and chronic, persistent biofilm-associated infections.

23.03.2026

HZI Campus

TWINCORE

Story

INFORBIO is a multidisciplinary project that combines participatory forest management by indigenous communities, agroforestry, the establishment of mobile health clinics, and the development of an early warning system for zoonotic disease surveillance through a multifaceted One Health approach. The overarching goal is to safeguard forests as natural barriers against the spread of zoonotic diseases while improving livelihoods in remote areas of the Central African Republic (CAR) and Cameroon. As part of INFORBIO, researchers at the Helmholtz Institute for One Health (HIOH), a site of the Helmholtz Centre for Infection Research (HZI), are developing early warning systems for zoonoses.

23.03.2026

HIOH

Aerial view of the Science Campus Braunschweig-Süd; in the foreground on the left is the building where AveThera GmbH will carry out GMP manufacturing

News

The Helmholtz Centre for Infection Research (HZI) welcomes the acquisition of the Braunschweig site of the Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM) by AveThera GmbH, effective March 16, 2026, as an important step for the region and particularly for the Science Campus Braunschweig-Süd. Core competencies in pharmaceutical biotechnology will remain in Braunschweig, while the Science Campus will be further strengthened as a center for the development and manufacturing of modern biopharmaceutical products.

16.03.2026

HZI Campus

Microscopic image of cells with blue cell nuclei and green and magenta-colored structures

News

An interdisciplinary consortium consisting of TWINCORE, Centre for Experimental and Clinical Infection Research, the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), the Helmholtz Centre for Infection Research (HZI) in Braunschweig, the University of Lübeck and Hannover Medical School (MHH), is receiving funding of around €999,000 from the Volkswagen Foundation. Under the leadership of Prof. Thomas Pietschmann, the team plans to optimize active substances against the respiratory syncytial virus (RSV) over the next two years. TWINCORE and HIPS are sites of the HZI in collaboration with MHH and Saarland University, respectively.

13.03.2026

TWINCORE

HIPS

HZI Campus

Groupphoto of Rainer Waldschmidt, Aditya Shekhar, Dominik Heimann, Stefan Bartoschek

News

The Science4Life Startup Competition supports teams of founders from the life sciences, chemistry, and energy sectors in transforming their excellent scientific ideas into marketable innovations. In the latest concept phase, the team behind the “PROTON” project from the Helmholtz Centre for Infection Research (HZI) was named the winner. PROTON is developing a novel active substance for the treatment of infections caused by the bacterium Staphylococcus aureus. Of the 91 applications for the concept phase of the Science4Life Venture Cup, the organizers invited ten teams to present their concepts. Ultimately, they selected five winning teams from the fields of life sciences and chemistry, as well as one team from the field of energy research.

12.03.2026

HZI Campus

Rolf Müller and Katharina Schaufler Portrait collage

News

Two researchers from the Helmholtz Centre for Infection Research (HZI) serve as advisors to a European consortium working to combat antimicrobial resistance. Prof. Rolf Müller, Scientific Director of the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and Head of the Research Unit “Novel Antibiotics” at the German Center for Infection Research (DZIF), and Prof. Katharina Schaufler, Head of the Department “Epidemiology and ecology of antimicrobial resistance” at the Helmholtz Institute for One Health, have been appointed to the Scientific Advisory Board of the European Partnership on One Health Antimicrobial Resistance (EUP OHAMR). HIPS and HIOH are sites of the HZI in collaboration with Saarland University and partner institutions in Greifswald, respectively.

12.03.2026

HIPS

HIOH

HZI in the media

Vor allem durch die Coronapandemie sind Forschende des Helmholtz-Zentrums für Infektionsforschung in den vergangenen Jahren bundesweit bekannt geworden. Auf welche Themen die Einrichtung für die Zukunft setzt.

20.03.2026

Deutsches Ärzteblatt

... beschäftigt sich daneben unter dem Dach des Helmholtz Institutes für Pharmazeutische Forschung Saarland (HIPS) ...

18.03.2026

Biermann Medizin

... Ausbau von Produktions- und Vermarktungskapazitäten.

Das Helmholtz-Zentrum für Infektionsforschung HZI begrüßt den Erhalt der GMP- ...

18.03.2026

Bionity.COM

... der Universität zu Lübeck, des Helmholtz-Zentrums für Infektionsforschung (HZI) in Braunschweig, der Medizinischen Hochschule Hannover ...

17.03.2026

Biermann Medizin

Vorsorge Das Coronavirus hält die Welt nicht mehr in Atem. Doch was, wenn ein anderer gefährlicher Erreger auftaucht? So wappnet sich unser Gesundheitssystem

16.03.2026

Apotheken Umschau

... stumpfen ab“, erklärt Marc Brönstrup vom Helmholtz-Zentrum für Infektionsforschung in Braunschweig. Neue Antibiotika sind dringend ...

14.03.2026

ARD Mediathek

... der Medizinischen Hochschule Hannover und dem Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig neue Wirkstoffe ...

13.03.2026

MTA Dialog

... späten 1990ern hob sie der am Saarbrücker Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS) tätige ...

08.03.2026

Saarbrücker Zeitung

European institutions, including Germany’s Helmholtz Institute for RNA-based Infection Research, Helmholtz Center for Infection Research,

06.03.2026

Clinical Lab Products

Die Zellen kontrollieren die Reaktion des Immunsystems und verhindern Schäden durch Selbstangriffe. Forschende arbeiten daran, sie zur Therapie einzusetzen.

05.03.2026

NDR Norddeutscher Rundfunk

Nachwuchsgruppe „Nanoinfektionsbiologie“ am HZI. Diese Lücke soll das Projekt ONEMUC (Respiratorischer Mukus als One Health-Schnittstelle) ...

03.03.2026

DeutschesGesundheitsPortal

Hochschule Hannover (MHH) und des Helmholz-Zentrums für Infektionsforschung (HZI) erforschen im Rahmen des Projektes StopPSC ( ...

03.03.2026

Biermann Medizin

Register now for the HZI-Newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.